2012 Scientific Report - Queensland Children's Medical Research ...
2012 Scientific Report - Queensland Children's Medical Research ...
2012 Scientific Report - Queensland Children's Medical Research ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>2012</strong>-<br />
2014<br />
<strong>2012</strong>-<br />
2015<br />
NHMRC O’Grady KA, Chang A,<br />
Grimwood K, Morris P,<br />
Smith-Vaughan H,<br />
Mulholland K, Torzillo<br />
P, Cripps A, Wood N,<br />
Revell A<br />
NHMRC Whiley D, Regan D,<br />
Donovan B, Chen M,<br />
Guy R, Lahra M<br />
A multi-centre, double blid,<br />
randomised controlled trial to<br />
evaluate the efficacy of 10<br />
valent-pneumococcal-<br />
Haemophilus influenzae-Protein<br />
D conjugate vaccine in reducing<br />
respiratory exacerbations in<br />
children aged >18 months with<br />
chronic suppurative lung<br />
disease<br />
Neisseria gonorrhoeae<br />
antmicrobial resistance:<br />
detection and propagation<br />
$1,122,492<br />
$419,900<br />
($316,000<br />
QPID)<br />
2013-<br />
2015<br />
NHMRC Upham, Mackay Understanding the mechanisms<br />
responsible for anti-viral<br />
immune dysfunction in asthma<br />
$285,000<br />
2011-<br />
2015<br />
NHMRC Early<br />
Career<br />
Fellowships<br />
Whiley D<br />
Acquisition and transmission of<br />
respiratory pathogens in<br />
persons with cystic fibrosis (CF):<br />
development and<br />
implementation of novel<br />
molecular tools<br />
$ 300,000<br />
2011-<br />
2013<br />
Novartis, Sloots TP Estimating Australian strain<br />
coverage of a multicomponent<br />
vaccine targeting serogroup B<br />
meningococci<br />
$487,340<br />
2013 Novartis, Sloots TP Evaluating anti-malarial drug<br />
efficacy in wild-type infections<br />
$184,750<br />
QCMRI <strong>Scientific</strong> <strong>Report</strong> <strong>2012</strong> 57
Change language